Dulaglutide

5 trials AGastroenterology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

4 Completed trials

5 Sponsors

6 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 2

Indications tested

Multiple sclerosis 1 Type 2 diabetes mellitus 1

Sponsors using this IMP

Bellvitge University Hospital 2 Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL 2 Comenius University Bratislava 1 Eli Lilly Cork Limited 1 Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA 1

All trials

5 total

Effects of GLP-1 analogue in multiple sclerosis Pending

2024-519235-42-00 Phase II 1 country Comenius University Bratislava
Clinical trial to evaluate whether personalized treatment based on genetics improves type 2 diabetes control Ended

2025-520686-46-00 Phase IV 1 country Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospita…
GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: randomized clinical trial. Study 1: Immediate Kidne… Ended

2023-506437-29-00 Phase III 1 country Bellvitge University Hospital; Fundacio Institut D'Investigacio Biomedica De Bel…
GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: a single-arm interventional clinical trial. Study 2… Ended

2023-506436-33-00 Phase III 1 country Bellvitge University Hospital; Fundacio Institut D'Investigacio Biomedica De Bel…
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 Phase IV 4 countries Eli Lilly Cork Limited

Showing 1–5 of 5 trials

← All drugs A–Z